Infection with SARS-CoV-2 has adverse outcomes for individuals with particular comorbid diseases, e.g., hypertension, obesity, type 2 DM, and other CVDs and this may be due to the presence of pre-existing ED and systemic inflammation in subjects with these conditions ( Cardiovascular/cardiometabolic comorbidities such as coronary artery disease (ischemic heart disease, coronary heart disease), hypertension, and DM dramatically increase the risk of in-hospital mortality in COVID-19 patients ( Thus SARS-CoV-2 infection may cause persistent CV symptoms following recovery from acute COVID-19 ( In a US study including more than 150 000 individuals, 1 year after SARS-CoV-2 infection, a significantly increased risk of a variety of CVDs, including heart failure, dysrhythmias, myocardial infarction, and stroke, independent of the severity of initial COVID-19 presentation was observed ( SARS-CoV-2 infection can cause significant vascular pathology, cardiac injury, and acute and chronic CV complications
For vitamin B deficiency (e.g., pernicious anemia), a common regimen is to begin with frequent intramuscular injections to replenish body stores
Store lyophilized powder at -20C for long-term storage
Impact of Toxins on Methylation and Glutathione Exposure to toxins, drugs, and chemicals in food can impact glutathione levels and methylation
"BPC 157 prevents muscle weakness following tendon trauma." J Appl Physiol
